Ionetix Corp / DE /

Pharmaceuticals · LANSING, MI

PharmaceuticalsSEC Form D

Ionetix Corp / DE / filed a Form D with the U.S. Securities and Exchange Commission on April 23, 2026, reporting $32,331,837 raised.

Incorporated in Delaware and based in LANSING, MI, it operates in the Pharmaceuticals sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Ionetix Corp / DE / has raised capital from private investors.

Browse more recently funded companies in Pharmaceuticals.

Executives & Directors

  • Kevin CameronExecutive Officer
  • Phieu PhunExecutive Officer
  • Gregory MartinDirector
  • Douglas BootheDirector
  • Michael StewartExecutive Officer · Director
  • David LandskowskyDirector

Recently funded in Pharmaceuticals

Other companies that recently filed a Form D

$50.0KRaised

Matthias Therapeutics, LLC

PharmaceuticalsBASKING RIDGE, NJ
May 14, 2026View SEC Form D
$5.3MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 11, 2026View SEC Form D
$2.5MRaised

GridAI Technologies Corp.

PharmaceuticalsBOCA RATON, FL
May 8, 2026View SEC Form D
$22.5MRaised

CNS Pharmaceuticals, Inc.

PharmaceuticalsHOUSTON, TX
May 4, 2026View SEC Form D
$4.9MRaised

California Compounding Company, Inc.

PharmaceuticalsLOS ANGELES, CA
May 1, 2026View SEC Form D
Ionetix Corp / DE / raised $32.3M — SEC Form D